BioLineRx

-$0.19 (-5.88%) As of 7:06 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioLineRx and other ETFs, options, and stocks.

About BLRX

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which focuses on oncology. Its oncology programs include Motaxafortide (BL-8040), which is therapy platform used in the treatment of pancreatic cancer; and AGI-134 is a immunotherapy treatment used fro multiple solid tumors.

CEO
Philip Adam Serlin
Employees
38
Headquarters
Modi'in, HaMerkaz
Founded
2003

BLRX Key Statistics

Market Cap
143.72M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
550.43K
High Today
$3.23
Low Today
$2.95
Open Price
$3.15
Volume
773.72K
52 Week High
$6.34
52 Week Low
$1.40

BLRX Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure